Gastric ulcerogenic and biological activities of N-3'a-propyphenazonyl-2-acetoxybenzamide.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D000983:Antipyrine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D001241:Aspirin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D004487:Edema / Q000188:drug therapy; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced*; D013329:Structure-Activity Relationship
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; C025764:N-3'a-propylphenazonyl-2-acetoxybenzamide; D001241:Aspirin; D000983:Antipyrine